nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—Auricular swelling—Lamivudine—hepatitis B	0.0264	0.0783	CcSEcCtD
Dasatinib—Aplasia pure red cell—Lamivudine—hepatitis B	0.0116	0.0344	CcSEcCtD
Dasatinib—STAT5B—blood plasma—hepatitis B	0.00905	0.0408	CbGeAlD
Dasatinib—Ascites—Entecavir—hepatitis B	0.00904	0.0268	CcSEcCtD
Dasatinib—Localised oedema—Lamivudine—hepatitis B	0.00753	0.0223	CcSEcCtD
Dasatinib—LYN—blood plasma—hepatitis B	0.00736	0.0332	CbGeAlD
Dasatinib—BTK—blood plasma—hepatitis B	0.00722	0.0325	CbGeAlD
Dasatinib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00689	0.0205	CcSEcCtD
Dasatinib—Myositis—Telbivudine—hepatitis B	0.00688	0.0204	CcSEcCtD
Dasatinib—TEC—blood—hepatitis B	0.00567	0.0256	CbGeAlD
Dasatinib—MAP3K2—blood plasma—hepatitis B	0.00539	0.0243	CbGeAlD
Dasatinib—MAPK14—blood plasma—hepatitis B	0.00507	0.0228	CbGeAlD
Dasatinib—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.0049	0.0145	CcSEcCtD
Dasatinib—JAK2—blood plasma—hepatitis B	0.00477	0.0215	CbGeAlD
Dasatinib—FYN—blood plasma—hepatitis B	0.00471	0.0212	CbGeAlD
Dasatinib—TEC—liver—hepatitis B	0.00444	0.02	CbGeAlD
Dasatinib—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00421	0.0125	CcSEcCtD
Dasatinib—SRC—blood plasma—hepatitis B	0.00408	0.0184	CbGeAlD
Dasatinib—PKMYT1—blood—hepatitis B	0.00383	0.0173	CbGeAlD
Dasatinib—Rhabdomyolysis—Telbivudine—hepatitis B	0.00381	0.0113	CcSEcCtD
Dasatinib—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00376	0.0112	CcSEcCtD
Dasatinib—BMX—blood—hepatitis B	0.00374	0.0169	CbGeAlD
Dasatinib—Cardiomyopathy—Lamivudine—hepatitis B	0.00372	0.011	CcSEcCtD
Dasatinib—BLK—blood—hepatitis B	0.0037	0.0167	CbGeAlD
Dasatinib—CSF1R—blood plasma—hepatitis B	0.00367	0.0165	CbGeAlD
Dasatinib—TXK—blood—hepatitis B	0.00354	0.016	CbGeAlD
Dasatinib—PTK6—blood—hepatitis B	0.00351	0.0158	CbGeAlD
Dasatinib—EPHB1—liver—hepatitis B	0.00348	0.0157	CbGeAlD
Dasatinib—Musculoskeletal pain—Telbivudine—hepatitis B	0.00341	0.0101	CcSEcCtD
Dasatinib—Gingival bleeding—Lamivudine—hepatitis B	0.00335	0.00994	CcSEcCtD
Dasatinib—KIT—blood plasma—hepatitis B	0.00333	0.015	CbGeAlD
Dasatinib—STAT5B—blood—hepatitis B	0.00332	0.0149	CbGeAlD
Dasatinib—SIK2—liver—hepatitis B	0.00308	0.0139	CbGeAlD
Dasatinib—FRK—liver—hepatitis B	0.003	0.0135	CbGeAlD
Dasatinib—Sepsis—Telbivudine—hepatitis B	0.00293	0.00869	CcSEcCtD
Dasatinib—Blood creatinine increased—Entecavir—hepatitis B	0.00279	0.00829	CcSEcCtD
Dasatinib—ZAK—blood—hepatitis B	0.00277	0.0125	CbGeAlD
Dasatinib—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00276	0.0082	CcSEcCtD
Dasatinib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00272	0.00809	CcSEcCtD
Dasatinib—LYN—blood—hepatitis B	0.0027	0.0122	CbGeAlD
Dasatinib—BTK—blood—hepatitis B	0.00264	0.0119	CbGeAlD
Dasatinib—STAT5B—liver—hepatitis B	0.00259	0.0117	CbGeAlD
Dasatinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00257	0.00761	CcSEcCtD
Dasatinib—Pancreatitis—Entecavir—hepatitis B	0.00253	0.0075	CcSEcCtD
Dasatinib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00246	0.00731	CcSEcCtD
Dasatinib—TESK1—blood—hepatitis B	0.00245	0.011	CbGeAlD
Dasatinib—STK36—blood—hepatitis B	0.00241	0.0109	CbGeAlD
Dasatinib—Neutropenia—Entecavir—hepatitis B	0.00241	0.00715	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00239	0.00711	CcSEcCtD
Dasatinib—SIK3—liver—hepatitis B	0.00233	0.0105	CbGeAlD
Dasatinib—LIMK2—blood—hepatitis B	0.00233	0.0105	CbGeAlD
Dasatinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00227	0.00675	CcSEcCtD
Dasatinib—Renal failure—Entecavir—hepatitis B	0.00226	0.0067	CcSEcCtD
Dasatinib—CSK—blood—hepatitis B	0.00224	0.0101	CbGeAlD
Dasatinib—HCK—blood—hepatitis B	0.00222	0.00998	CbGeAlD
Dasatinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00221	0.00654	CcSEcCtD
Dasatinib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.0022	0.00654	CcSEcCtD
Dasatinib—ABL2—blood—hepatitis B	0.0022	0.00992	CbGeAlD
Dasatinib—Haematuria—Entecavir—hepatitis B	0.00219	0.0065	CcSEcCtD
Dasatinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00217	0.00645	CcSEcCtD
Dasatinib—Gastritis—Telbivudine—hepatitis B	0.00217	0.00643	CcSEcCtD
Dasatinib—ZAK—liver—hepatitis B	0.00217	0.00976	CbGeAlD
Dasatinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00216	0.00641	CcSEcCtD
Dasatinib—Muscular weakness—Telbivudine—hepatitis B	0.00216	0.00641	CcSEcCtD
Dasatinib—Rhabdomyolysis—Lamivudine—hepatitis B	0.00215	0.00638	CcSEcCtD
Dasatinib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00214	0.00634	CcSEcCtD
Dasatinib—Abdominal distension—Telbivudine—hepatitis B	0.00213	0.00632	CcSEcCtD
Dasatinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00212	0.00629	CcSEcCtD
Dasatinib—LYN—liver—hepatitis B	0.00211	0.0095	CbGeAlD
Dasatinib—RIPK2—blood—hepatitis B	0.00208	0.00938	CbGeAlD
Dasatinib—BTK—liver—hepatitis B	0.00207	0.00931	CbGeAlD
Dasatinib—Hepatitis—Entecavir—hepatitis B	0.00206	0.00612	CcSEcCtD
Dasatinib—TNK2—liver—hepatitis B	0.00204	0.00918	CbGeAlD
Dasatinib—SIK1—blood—hepatitis B	0.00203	0.00916	CbGeAlD
Dasatinib—Oedema peripheral—Entecavir—hepatitis B	0.00203	0.00603	CcSEcCtD
Dasatinib—EPHA4—blood—hepatitis B	0.00201	0.00907	CbGeAlD
Dasatinib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00201	0.00597	CcSEcCtD
Dasatinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00199	0.0059	CcSEcCtD
Dasatinib—Neutropenia—Telbivudine—hepatitis B	0.00198	0.00587	CcSEcCtD
Dasatinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00198	0.00587	CcSEcCtD
Dasatinib—MAP3K2—blood—hepatitis B	0.00197	0.0089	CbGeAlD
Dasatinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00197	0.00585	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00197	0.00584	CcSEcCtD
Dasatinib—Inflammation—Lamivudine—hepatitis B	0.00196	0.00582	CcSEcCtD
Dasatinib—Musculoskeletal pain—Lamivudine—hepatitis B	0.00192	0.00571	CcSEcCtD
Dasatinib—TESK1—liver—hepatitis B	0.00192	0.00863	CbGeAlD
Dasatinib—STK36—liver—hepatitis B	0.00189	0.00849	CbGeAlD
Dasatinib—Immune system disorder—Entecavir—hepatitis B	0.00186	0.00553	CcSEcCtD
Dasatinib—MAPK14—blood—hepatitis B	0.00186	0.00836	CbGeAlD
Dasatinib—Renal failure—Telbivudine—hepatitis B	0.00186	0.0055	CcSEcCtD
Dasatinib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00185	0.00549	CcSEcCtD
Dasatinib—FGR—blood—hepatitis B	0.00185	0.00833	CbGeAlD
Dasatinib—LCK—blood—hepatitis B	0.00185	0.00833	CbGeAlD
Dasatinib—LIMK2—liver—hepatitis B	0.00182	0.00821	CbGeAlD
Dasatinib—Alopecia—Entecavir—hepatitis B	0.00182	0.00541	CcSEcCtD
Dasatinib—Mental disorder—Entecavir—hepatitis B	0.00181	0.00536	CcSEcCtD
Dasatinib—Malnutrition—Entecavir—hepatitis B	0.0018	0.00533	CcSEcCtD
Dasatinib—Neuropathy—Lamivudine—hepatitis B	0.00179	0.0053	CcSEcCtD
Dasatinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00178	0.0053	CcSEcCtD
Dasatinib—STK35—liver—hepatitis B	0.00177	0.00796	CbGeAlD
Dasatinib—EPHB4—blood—hepatitis B	0.00176	0.00793	CbGeAlD
Dasatinib—CYP1A2—blood plasma—hepatitis B	0.00176	0.00793	CbGeAlD
Dasatinib—CSK—liver—hepatitis B	0.00175	0.00791	CbGeAlD
Dasatinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00175	0.0052	CcSEcCtD
Dasatinib—JAK2—blood—hepatitis B	0.00175	0.00787	CbGeAlD
Dasatinib—HCK—liver—hepatitis B	0.00173	0.0078	CbGeAlD
Dasatinib—EPHA2—blood—hepatitis B	0.00173	0.00778	CbGeAlD
Dasatinib—FYN—blood—hepatitis B	0.00172	0.00776	CbGeAlD
Dasatinib—ABL2—liver—hepatitis B	0.00172	0.00776	CbGeAlD
Dasatinib—Gynaecomastia—Lamivudine—hepatitis B	0.0017	0.00505	CcSEcCtD
Dasatinib—CYP3A5—blood plasma—hepatitis B	0.0017	0.00764	CbGeAlD
Dasatinib—Hepatitis—Telbivudine—hepatitis B	0.00169	0.00503	CcSEcCtD
Dasatinib—MAP4K5—blood—hepatitis B	0.00168	0.00759	CbGeAlD
Dasatinib—MAP3K3—blood—hepatitis B	0.00168	0.00759	CbGeAlD
Dasatinib—Connective tissue disorder—Telbivudine—hepatitis B	0.00166	0.00494	CcSEcCtD
Dasatinib—Sepsis—Lamivudine—hepatitis B	0.00165	0.0049	CcSEcCtD
Dasatinib—RIPK2—liver—hepatitis B	0.00163	0.00734	CbGeAlD
Dasatinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00162	0.0048	CcSEcCtD
Dasatinib—EPHB6—blood—hepatitis B	0.00161	0.00725	CbGeAlD
Dasatinib—SIK1—liver—hepatitis B	0.00159	0.00717	CbGeAlD
Dasatinib—ERBB3—liver—hepatitis B	0.00156	0.00702	CbGeAlD
Dasatinib—YES1—blood—hepatitis B	0.00156	0.00701	CbGeAlD
Dasatinib—MAP3K2—liver—hepatitis B	0.00154	0.00696	CbGeAlD
Dasatinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00153	0.00454	CcSEcCtD
Dasatinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00153	0.00453	CcSEcCtD
Dasatinib—PDGFRA—blood—hepatitis B	0.00153	0.00687	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00152	0.0045	CcSEcCtD
Dasatinib—SRC—blood—hepatitis B	0.0015	0.00674	CbGeAlD
Dasatinib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00149	0.00443	CcSEcCtD
Dasatinib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00149	0.00443	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00148	0.00439	CcSEcCtD
Dasatinib—Malnutrition—Telbivudine—hepatitis B	0.00147	0.00438	CcSEcCtD
Dasatinib—Infection—Entecavir—hepatitis B	0.00146	0.00432	CcSEcCtD
Dasatinib—MAPK14—liver—hepatitis B	0.00145	0.00654	CbGeAlD
Dasatinib—FGR—liver—hepatitis B	0.00145	0.00651	CbGeAlD
Dasatinib—LCK—liver—hepatitis B	0.00145	0.00651	CbGeAlD
Dasatinib—Dysgeusia—Telbivudine—hepatitis B	0.00144	0.00429	CcSEcCtD
Dasatinib—Nervous system disorder—Entecavir—hepatitis B	0.00144	0.00426	CcSEcCtD
Dasatinib—Skin disorder—Entecavir—hepatitis B	0.00142	0.00422	CcSEcCtD
Dasatinib—Muscle spasms—Telbivudine—hepatitis B	0.00142	0.00421	CcSEcCtD
Dasatinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0014	0.00416	CcSEcCtD
Dasatinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0014	0.00415	CcSEcCtD
Dasatinib—FMO3—liver—hepatitis B	0.0014	0.00629	CbGeAlD
Dasatinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00139	0.00412	CcSEcCtD
Dasatinib—MAP2K5—blood—hepatitis B	0.00138	0.0062	CbGeAlD
Dasatinib—EPHB4—liver—hepatitis B	0.00138	0.0062	CbGeAlD
Dasatinib—Ill-defined disorder—Telbivudine—hepatitis B	0.00137	0.00406	CcSEcCtD
Dasatinib—JAK2—liver—hepatitis B	0.00137	0.00616	CbGeAlD
Dasatinib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00136	0.00404	CcSEcCtD
Dasatinib—Affect lability—Lamivudine—hepatitis B	0.00136	0.00403	CcSEcCtD
Dasatinib—EPHA2—liver—hepatitis B	0.00135	0.00608	CbGeAlD
Dasatinib—FYN—liver—hepatitis B	0.00135	0.00607	CbGeAlD
Dasatinib—CSF1R—blood—hepatitis B	0.00134	0.00605	CbGeAlD
Dasatinib—Malaise—Telbivudine—hepatitis B	0.00133	0.00395	CcSEcCtD
Dasatinib—Insomnia—Entecavir—hepatitis B	0.00133	0.00393	CcSEcCtD
Dasatinib—MAP4K5—liver—hepatitis B	0.00132	0.00593	CbGeAlD
Dasatinib—MAP3K3—liver—hepatitis B	0.00132	0.00593	CbGeAlD
Dasatinib—Somnolence—Entecavir—hepatitis B	0.0013	0.00387	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.0013	0.00386	CcSEcCtD
Dasatinib—Dyspepsia—Entecavir—hepatitis B	0.00129	0.00383	CcSEcCtD
Dasatinib—Cough—Telbivudine—hepatitis B	0.00129	0.00382	CcSEcCtD
Dasatinib—CYP3A4—blood plasma—hepatitis B	0.00127	0.00574	CbGeAlD
Dasatinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00126	0.00375	CcSEcCtD
Dasatinib—Fatigue—Entecavir—hepatitis B	0.00126	0.00375	CcSEcCtD
Dasatinib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00126	0.00373	CcSEcCtD
Dasatinib—Arthralgia—Telbivudine—hepatitis B	0.00126	0.00373	CcSEcCtD
Dasatinib—Myalgia—Telbivudine—hepatitis B	0.00126	0.00373	CcSEcCtD
Dasatinib—Chest pain—Telbivudine—hepatitis B	0.00126	0.00373	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00125	0.0037	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00124	0.00369	CcSEcCtD
Dasatinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00124	0.00369	CcSEcCtD
Dasatinib—Discomfort—Telbivudine—hepatitis B	0.00124	0.00368	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00123	0.00366	CcSEcCtD
Dasatinib—KIT—blood—hepatitis B	0.00122	0.0055	CbGeAlD
Dasatinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00122	0.00361	CcSEcCtD
Dasatinib—Muscular weakness—Lamivudine—hepatitis B	0.00122	0.00361	CcSEcCtD
Dasatinib—YES1—liver—hepatitis B	0.00122	0.00548	CbGeAlD
Dasatinib—Abdominal distension—Lamivudine—hepatitis B	0.0012	0.00356	CcSEcCtD
Dasatinib—Gastrointestinal pain—Entecavir—hepatitis B	0.0012	0.00356	CcSEcCtD
Dasatinib—PDGFRA—liver—hepatitis B	0.00119	0.00538	CbGeAlD
Dasatinib—Dysphagia—Lamivudine—hepatitis B	0.00119	0.00354	CcSEcCtD
Dasatinib—PDGFRB—blood—hepatitis B	0.00119	0.00537	CbGeAlD
Dasatinib—Nervous system disorder—Telbivudine—hepatitis B	0.00118	0.0035	CcSEcCtD
Dasatinib—Thrombocytopenia—Telbivudine—hepatitis B	0.00118	0.0035	CcSEcCtD
Dasatinib—SRC—liver—hepatitis B	0.00117	0.00527	CbGeAlD
Dasatinib—Pancreatitis—Lamivudine—hepatitis B	0.00117	0.00347	CcSEcCtD
Dasatinib—Skin disorder—Telbivudine—hepatitis B	0.00117	0.00347	CcSEcCtD
Dasatinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00117	0.00347	CcSEcCtD
Dasatinib—Abdominal pain—Entecavir—hepatitis B	0.00116	0.00344	CcSEcCtD
Dasatinib—Body temperature increased—Entecavir—hepatitis B	0.00116	0.00344	CcSEcCtD
Dasatinib—Pancytopenia—Lamivudine—hepatitis B	0.00113	0.00336	CcSEcCtD
Dasatinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00113	0.00335	CcSEcCtD
Dasatinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00113	0.00335	CcSEcCtD
Dasatinib—Neutropenia—Lamivudine—hepatitis B	0.00112	0.00331	CcSEcCtD
Dasatinib—Pollakiuria—Lamivudine—hepatitis B	0.0011	0.00327	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0011	0.00325	CcSEcCtD
Dasatinib—Insomnia—Telbivudine—hepatitis B	0.00109	0.00323	CcSEcCtD
Dasatinib—MAP2K5—liver—hepatitis B	0.00108	0.00485	CbGeAlD
Dasatinib—ABL1—blood—hepatitis B	0.00106	0.00478	CbGeAlD
Dasatinib—Dyspepsia—Telbivudine—hepatitis B	0.00106	0.00314	CcSEcCtD
Dasatinib—Asthenia—Entecavir—hepatitis B	0.00105	0.00312	CcSEcCtD
Dasatinib—CSF1R—liver—hepatitis B	0.00105	0.00473	CbGeAlD
Dasatinib—Renal failure—Lamivudine—hepatitis B	0.00105	0.0031	CcSEcCtD
Dasatinib—Neuropathy peripheral—Lamivudine—hepatitis B	0.00104	0.00309	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00104	0.00308	CcSEcCtD
Dasatinib—Fatigue—Telbivudine—hepatitis B	0.00104	0.00308	CcSEcCtD
Dasatinib—Stomatitis—Lamivudine—hepatitis B	0.00104	0.00308	CcSEcCtD
Dasatinib—Pain—Telbivudine—hepatitis B	0.00103	0.00305	CcSEcCtD
Dasatinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00103	0.00304	CcSEcCtD
Dasatinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00101	0.003	CcSEcCtD
Dasatinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00101	0.00298	CcSEcCtD
Dasatinib—Epistaxis—Lamivudine—hepatitis B	0.001	0.00298	CcSEcCtD
Dasatinib—Diarrhoea—Entecavir—hepatitis B	0.001	0.00297	CcSEcCtD
Dasatinib—Feeling abnormal—Telbivudine—hepatitis B	0.000992	0.00294	CcSEcCtD
Dasatinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.000984	0.00292	CcSEcCtD
Dasatinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000978	0.0029	CcSEcCtD
Dasatinib—Dizziness—Entecavir—hepatitis B	0.000969	0.00288	CcSEcCtD
Dasatinib—Hepatitis—Lamivudine—hepatitis B	0.000955	0.00283	CcSEcCtD
Dasatinib—KIT—liver—hepatitis B	0.000954	0.0043	CbGeAlD
Dasatinib—Abdominal pain—Telbivudine—hepatitis B	0.000952	0.00282	CcSEcCtD
Dasatinib—Body temperature increased—Telbivudine—hepatitis B	0.000952	0.00282	CcSEcCtD
Dasatinib—Connective tissue disorder—Lamivudine—hepatitis B	0.000938	0.00278	CcSEcCtD
Dasatinib—PDGFRB—liver—hepatitis B	0.000932	0.0042	CbGeAlD
Dasatinib—Vomiting—Entecavir—hepatitis B	0.000932	0.00276	CcSEcCtD
Dasatinib—Rash—Entecavir—hepatitis B	0.000924	0.00274	CcSEcCtD
Dasatinib—Dermatitis—Entecavir—hepatitis B	0.000923	0.00274	CcSEcCtD
Dasatinib—Headache—Entecavir—hepatitis B	0.000918	0.00272	CcSEcCtD
Dasatinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000909	0.0027	CcSEcCtD
Dasatinib—Erythema multiforme—Lamivudine—hepatitis B	0.000903	0.00268	CcSEcCtD
Dasatinib—ABCB1—blood plasma—hepatitis B	0.000901	0.00406	CbGeAlD
Dasatinib—Rash—Adefovir Dipivoxil—hepatitis B	0.000901	0.00267	CcSEcCtD
Dasatinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000901	0.00267	CcSEcCtD
Dasatinib—CYP1B1—blood—hepatitis B	0.000899	0.00405	CbGeAlD
Dasatinib—Headache—Adefovir Dipivoxil—hepatitis B	0.000896	0.00266	CcSEcCtD
Dasatinib—Nausea—Entecavir—hepatitis B	0.00087	0.00258	CcSEcCtD
Dasatinib—Asthenia—Telbivudine—hepatitis B	0.000864	0.00256	CcSEcCtD
Dasatinib—Immune system disorder—Lamivudine—hepatitis B	0.000862	0.00256	CcSEcCtD
Dasatinib—Mediastinal disorder—Lamivudine—hepatitis B	0.000861	0.00255	CcSEcCtD
Dasatinib—Chills—Lamivudine—hepatitis B	0.000857	0.00254	CcSEcCtD
Dasatinib—Pruritus—Telbivudine—hepatitis B	0.000852	0.00253	CcSEcCtD
Dasatinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.000849	0.00252	CcSEcCtD
Dasatinib—Alopecia—Lamivudine—hepatitis B	0.000844	0.0025	CcSEcCtD
Dasatinib—Erythema—Lamivudine—hepatitis B	0.000831	0.00247	CcSEcCtD
Dasatinib—Malnutrition—Lamivudine—hepatitis B	0.000831	0.00247	CcSEcCtD
Dasatinib—ABL1—liver—hepatitis B	0.00083	0.00374	CbGeAlD
Dasatinib—Diarrhoea—Telbivudine—hepatitis B	0.000824	0.00244	CcSEcCtD
Dasatinib—Dysgeusia—Lamivudine—hepatitis B	0.000814	0.00242	CcSEcCtD
Dasatinib—Muscle spasms—Lamivudine—hepatitis B	0.000799	0.00237	CcSEcCtD
Dasatinib—Dizziness—Telbivudine—hepatitis B	0.000796	0.00236	CcSEcCtD
Dasatinib—Tremor—Lamivudine—hepatitis B	0.000779	0.00231	CcSEcCtD
Dasatinib—Ill-defined disorder—Lamivudine—hepatitis B	0.000771	0.00229	CcSEcCtD
Dasatinib—Anaemia—Lamivudine—hepatitis B	0.000768	0.00228	CcSEcCtD
Dasatinib—Vomiting—Telbivudine—hepatitis B	0.000765	0.00227	CcSEcCtD
Dasatinib—Rash—Telbivudine—hepatitis B	0.000759	0.00225	CcSEcCtD
Dasatinib—Dermatitis—Telbivudine—hepatitis B	0.000758	0.00225	CcSEcCtD
Dasatinib—Headache—Telbivudine—hepatitis B	0.000754	0.00224	CcSEcCtD
Dasatinib—Malaise—Lamivudine—hepatitis B	0.00075	0.00222	CcSEcCtD
Dasatinib—Vertigo—Lamivudine—hepatitis B	0.000747	0.00222	CcSEcCtD
Dasatinib—Syncope—Lamivudine—hepatitis B	0.000745	0.00221	CcSEcCtD
Dasatinib—Loss of consciousness—Lamivudine—hepatitis B	0.000731	0.00217	CcSEcCtD
Dasatinib—Cough—Lamivudine—hepatitis B	0.000725	0.00215	CcSEcCtD
Dasatinib—Convulsion—Lamivudine—hepatitis B	0.00072	0.00214	CcSEcCtD
Dasatinib—Nausea—Telbivudine—hepatitis B	0.000715	0.00212	CcSEcCtD
Dasatinib—Arthralgia—Lamivudine—hepatitis B	0.000708	0.0021	CcSEcCtD
Dasatinib—Myalgia—Lamivudine—hepatitis B	0.000708	0.0021	CcSEcCtD
Dasatinib—Chest pain—Lamivudine—hepatitis B	0.000708	0.0021	CcSEcCtD
Dasatinib—Anxiety—Lamivudine—hepatitis B	0.000705	0.00209	CcSEcCtD
Dasatinib—CYP1B1—liver—hepatitis B	0.000703	0.00317	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000703	0.00209	CcSEcCtD
Dasatinib—Discomfort—Lamivudine—hepatitis B	0.000699	0.00207	CcSEcCtD
Dasatinib—Confusional state—Lamivudine—hepatitis B	0.000684	0.00203	CcSEcCtD
Dasatinib—Oedema—Lamivudine—hepatitis B	0.000678	0.00201	CcSEcCtD
Dasatinib—Infection—Lamivudine—hepatitis B	0.000674	0.002	CcSEcCtD
Dasatinib—ABCG2—blood—hepatitis B	0.00067	0.00302	CbGeAlD
Dasatinib—Shock—Lamivudine—hepatitis B	0.000667	0.00198	CcSEcCtD
Dasatinib—Nervous system disorder—Lamivudine—hepatitis B	0.000665	0.00197	CcSEcCtD
Dasatinib—Thrombocytopenia—Lamivudine—hepatitis B	0.000664	0.00197	CcSEcCtD
Dasatinib—Skin disorder—Lamivudine—hepatitis B	0.000659	0.00196	CcSEcCtD
Dasatinib—Hyperhidrosis—Lamivudine—hepatitis B	0.000656	0.00195	CcSEcCtD
Dasatinib—Anorexia—Lamivudine—hepatitis B	0.000647	0.00192	CcSEcCtD
Dasatinib—CYP1A2—blood—hepatitis B	0.000645	0.0029	CbGeAlD
Dasatinib—CYP1A1—blood—hepatitis B	0.000636	0.00286	CbGeAlD
Dasatinib—Hypotension—Lamivudine—hepatitis B	0.000634	0.00188	CcSEcCtD
Dasatinib—CYP3A5—blood—hepatitis B	0.000622	0.0028	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000618	0.00183	CcSEcCtD
Dasatinib—Insomnia—Lamivudine—hepatitis B	0.000614	0.00182	CcSEcCtD
Dasatinib—Dyspnoea—Lamivudine—hepatitis B	0.000605	0.00179	CcSEcCtD
Dasatinib—Somnolence—Lamivudine—hepatitis B	0.000603	0.00179	CcSEcCtD
Dasatinib—Dyspepsia—Lamivudine—hepatitis B	0.000597	0.00177	CcSEcCtD
Dasatinib—Decreased appetite—Lamivudine—hepatitis B	0.00059	0.00175	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000586	0.00174	CcSEcCtD
Dasatinib—Fatigue—Lamivudine—hepatitis B	0.000585	0.00174	CcSEcCtD
Dasatinib—Constipation—Lamivudine—hepatitis B	0.00058	0.00172	CcSEcCtD
Dasatinib—Pain—Lamivudine—hepatitis B	0.00058	0.00172	CcSEcCtD
Dasatinib—Feeling abnormal—Lamivudine—hepatitis B	0.000559	0.00166	CcSEcCtD
Dasatinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000555	0.00165	CcSEcCtD
Dasatinib—Urticaria—Lamivudine—hepatitis B	0.000539	0.0016	CcSEcCtD
Dasatinib—Abdominal pain—Lamivudine—hepatitis B	0.000536	0.00159	CcSEcCtD
Dasatinib—Body temperature increased—Lamivudine—hepatitis B	0.000536	0.00159	CcSEcCtD
Dasatinib—ABCG2—liver—hepatitis B	0.000524	0.00236	CbGeAlD
Dasatinib—CYP1A2—liver—hepatitis B	0.000504	0.00227	CbGeAlD
Dasatinib—Hypersensitivity—Lamivudine—hepatitis B	0.0005	0.00148	CcSEcCtD
Dasatinib—CYP1A1—liver—hepatitis B	0.000497	0.00224	CbGeAlD
Dasatinib—Asthenia—Lamivudine—hepatitis B	0.000487	0.00144	CcSEcCtD
Dasatinib—CYP3A5—liver—hepatitis B	0.000486	0.00219	CbGeAlD
Dasatinib—Pruritus—Lamivudine—hepatitis B	0.00048	0.00142	CcSEcCtD
Dasatinib—CYP3A4—blood—hepatitis B	0.000467	0.0021	CbGeAlD
Dasatinib—Diarrhoea—Lamivudine—hepatitis B	0.000464	0.00138	CcSEcCtD
Dasatinib—Dizziness—Lamivudine—hepatitis B	0.000449	0.00133	CcSEcCtD
Dasatinib—Vomiting—Lamivudine—hepatitis B	0.000431	0.00128	CcSEcCtD
Dasatinib—Rash—Lamivudine—hepatitis B	0.000428	0.00127	CcSEcCtD
Dasatinib—Dermatitis—Lamivudine—hepatitis B	0.000427	0.00127	CcSEcCtD
Dasatinib—Headache—Lamivudine—hepatitis B	0.000425	0.00126	CcSEcCtD
Dasatinib—Nausea—Lamivudine—hepatitis B	0.000403	0.0012	CcSEcCtD
Dasatinib—CYP3A4—liver—hepatitis B	0.000365	0.00164	CbGeAlD
Dasatinib—ABCB1—blood—hepatitis B	0.00033	0.00149	CbGeAlD
Dasatinib—ABCB1—liver—hepatitis B	0.000258	0.00116	CbGeAlD
Dasatinib—LYN—Innate Immune System—IL6—hepatitis B	1.08e-05	2.46e-05	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—IL6—hepatitis B	1.08e-05	2.44e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TP53—hepatitis B	1.08e-05	2.44e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT2—hepatitis B	1.08e-05	2.44e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL2—hepatitis B	1.07e-05	2.43e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—IL6—hepatitis B	1.07e-05	2.43e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL2—hepatitis B	1.07e-05	2.42e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TP53—hepatitis B	1.07e-05	2.42e-05	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—IL6—hepatitis B	1.07e-05	2.42e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CTNNB1—hepatitis B	1.06e-05	2.41e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD4—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL2—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CDKN1A—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CTNNB1—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP2A6—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—PTEN—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL2—hepatitis B	1.06e-05	2.4e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS2—hepatitis B	1.05e-05	2.39e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—F2—hepatitis B	1.05e-05	2.39e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL6—hepatitis B	1.05e-05	2.38e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL6—hepatitis B	1.05e-05	2.38e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CDKN1A—hepatitis B	1.04e-05	2.35e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CTNNB1—hepatitis B	1.04e-05	2.35e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—PTEN—hepatitis B	1.03e-05	2.35e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GGT1—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT1—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CDKN1A—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—PTEN—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CTNNB1—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—F2—hepatitis B	1.03e-05	2.34e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NFKB1—hepatitis B	1.03e-05	2.33e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—IL6—hepatitis B	1.03e-05	2.33e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NFKB1—hepatitis B	1.03e-05	2.33e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CTNNB1—hepatitis B	1.02e-05	2.32e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CTNNB1—hepatitis B	1.02e-05	2.31e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—hepatitis B	1.02e-05	2.31e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—F2—hepatitis B	1.01e-05	2.3e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—IL6—hepatitis B	1.01e-05	2.3e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CDKN1A—hepatitis B	1.01e-05	2.29e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—PTEN—hepatitis B	1.01e-05	2.29e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—hepatitis B	1.01e-05	2.28e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CDKN1A—hepatitis B	1.01e-05	2.28e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—PTEN—hepatitis B	1e-05	2.28e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—NFKB1—hepatitis B	1e-05	2.28e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—hepatitis B	1e-05	2.28e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NFKB1—hepatitis B	1e-05	2.27e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CDKN1A—hepatitis B	9.99e-06	2.27e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—PTEN—hepatitis B	9.97e-06	2.26e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CDKN1A—hepatitis B	9.96e-06	2.26e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—PTEN—hepatitis B	9.94e-06	2.25e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NFKB1—hepatitis B	9.92e-06	2.25e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—hepatitis B	9.9e-06	2.24e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—NFKB1—hepatitis B	9.89e-06	2.24e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCR5—hepatitis B	9.84e-06	2.23e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CTNNB1—hepatitis B	9.82e-06	2.23e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—hepatitis B	9.77e-06	2.22e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CTNNB1—hepatitis B	9.77e-06	2.21e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—F2—hepatitis B	9.76e-06	2.21e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CTNNB1—hepatitis B	9.69e-06	2.2e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—F2—hepatitis B	9.64e-06	2.19e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—hepatitis B	9.63e-06	2.18e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CDKN1A—hepatitis B	9.59e-06	2.17e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—PTEN—hepatitis B	9.57e-06	2.17e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT2—hepatitis B	9.56e-06	2.17e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—hepatitis B	9.56e-06	2.17e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CDKN1A—hepatitis B	9.54e-06	2.16e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—hepatitis B	9.53e-06	2.16e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NFKB1—hepatitis B	9.52e-06	2.16e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—PTEN—hepatitis B	9.52e-06	2.16e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CDKN1A—hepatitis B	9.47e-06	2.15e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—hepatitis B	9.46e-06	2.15e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—PTEN—hepatitis B	9.45e-06	2.14e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.42e-06	2.14e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CTNNB1—hepatitis B	9.41e-06	2.13e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NFKB1—hepatitis B	9.4e-06	2.13e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	9.38e-06	2.13e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—hepatitis B	9.38e-06	2.13e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—hepatitis B	9.3e-06	2.11e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—hepatitis B	9.25e-06	2.1e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CDKN1A—hepatitis B	9.2e-06	2.09e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—PTEN—hepatitis B	9.18e-06	2.08e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CTNNB1—hepatitis B	8.98e-06	2.04e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CTNNB1—hepatitis B	8.95e-06	2.03e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—hepatitis B	8.93e-06	2.02e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—hepatitis B	8.9e-06	2.02e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—hepatitis B	8.9e-06	2.02e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—hepatitis B	8.87e-06	2.01e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—hepatitis B	8.82e-06	2e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—hepatitis B	8.79e-06	1.99e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CDKN1A—hepatitis B	8.77e-06	1.99e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—hepatitis B	8.76e-06	1.99e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—hepatitis B	8.76e-06	1.99e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PTEN—hepatitis B	8.75e-06	1.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CDKN1A—hepatitis B	8.74e-06	1.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—PTEN—hepatitis B	8.72e-06	1.98e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—hepatitis B	8.71e-06	1.98e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NFKB1—hepatitis B	8.71e-06	1.98e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—hepatitis B	8.58e-06	1.94e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CTNNB1—hepatitis B	8.49e-06	1.92e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—hepatitis B	8.46e-06	1.92e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—hepatitis B	8.46e-06	1.92e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2A6—hepatitis B	8.44e-06	1.91e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—F2—hepatitis B	8.44e-06	1.91e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—hepatitis B	8.31e-06	1.88e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CDKN1A—hepatitis B	8.29e-06	1.88e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—PTEN—hepatitis B	8.27e-06	1.88e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—hepatitis B	8.27e-06	1.87e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT1—hepatitis B	8.26e-06	1.87e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT1—hepatitis B	8.26e-06	1.87e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—NFKB1—hepatitis B	8.23e-06	1.87e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—hepatitis B	8.12e-06	1.84e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CTNNB1—hepatitis B	8.02e-06	1.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—hepatitis B	7.89e-06	1.79e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.87e-06	1.79e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—hepatitis B	7.86e-06	1.78e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—hepatitis B	7.86e-06	1.78e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CTNNB1—hepatitis B	7.84e-06	1.78e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CDKN1A—hepatitis B	7.83e-06	1.78e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PTEN—hepatitis B	7.82e-06	1.77e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—hepatitis B	7.81e-06	1.77e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—hepatitis B	7.78e-06	1.77e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NFKB1—hepatitis B	7.78e-06	1.76e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—hepatitis B	7.72e-06	1.75e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CDKN1A—hepatitis B	7.66e-06	1.74e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTEN—hepatitis B	7.64e-06	1.73e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT2—hepatitis B	7.64e-06	1.73e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—hepatitis B	7.61e-06	1.72e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CTNNB1—hepatitis B	7.59e-06	1.72e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—hepatitis B	7.55e-06	1.71e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CTNNB1—hepatitis B	7.52e-06	1.7e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—F2—hepatitis B	7.47e-06	1.69e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CDKN1A—hepatitis B	7.42e-06	1.68e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PTEN—hepatitis B	7.4e-06	1.68e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NFKB1—hepatitis B	7.36e-06	1.67e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CDKN1A—hepatitis B	7.34e-06	1.66e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—PTEN—hepatitis B	7.32e-06	1.66e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—NFKB1—hepatitis B	7.29e-06	1.65e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—hepatitis B	7.26e-06	1.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—hepatitis B	7.23e-06	1.64e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—hepatitis B	7.15e-06	1.62e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—hepatitis B	7.08e-06	1.61e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—hepatitis B	7.07e-06	1.6e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—hepatitis B	7.06e-06	1.6e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—hepatitis B	6.97e-06	1.58e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CTNNB1—hepatitis B	6.94e-06	1.57e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—hepatitis B	6.94e-06	1.57e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CTNNB1—hepatitis B	6.84e-06	1.55e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—hepatitis B	6.83e-06	1.55e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTEN—hepatitis B	6.81e-06	1.54e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—hepatitis B	6.81e-06	1.54e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CDKN1A—hepatitis B	6.78e-06	1.54e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PTEN—hepatitis B	6.76e-06	1.53e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CTNNB1—hepatitis B	6.7e-06	1.52e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CDKN1A—hepatitis B	6.68e-06	1.52e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PTEN—hepatitis B	6.67e-06	1.51e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NFKB1—hepatitis B	6.63e-06	1.5e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—hepatitis B	6.6e-06	1.5e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CTNNB1—hepatitis B	6.59e-06	1.49e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—hepatitis B	6.59e-06	1.49e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—hepatitis B	6.59e-06	1.49e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—hepatitis B	6.58e-06	1.49e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CDKN1A—hepatitis B	6.54e-06	1.48e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PTEN—hepatitis B	6.53e-06	1.48e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	6.52e-06	1.48e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NFKB1—hepatitis B	6.5e-06	1.47e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—hepatitis B	6.49e-06	1.47e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—hepatitis B	6.48e-06	1.47e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—hepatitis B	6.46e-06	1.47e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—hepatitis B	6.46e-06	1.46e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—hepatitis B	6.44e-06	1.46e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CDKN1A—hepatitis B	6.44e-06	1.46e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PTEN—hepatitis B	6.43e-06	1.46e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NFKB1—hepatitis B	6.39e-06	1.45e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CTNNB1—hepatitis B	6.35e-06	1.44e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—hepatitis B	6.33e-06	1.44e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—hepatitis B	6.31e-06	1.43e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—hepatitis B	6.28e-06	1.42e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CTNNB1—hepatitis B	6.27e-06	1.42e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—hepatitis B	6.23e-06	1.41e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—hepatitis B	6.21e-06	1.41e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CDKN1A—hepatitis B	6.2e-06	1.41e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTEN—hepatitis B	6.2e-06	1.41e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PTEN—hepatitis B	6.19e-06	1.4e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NFKB1—hepatitis B	6.16e-06	1.4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—hepatitis B	6.13e-06	1.39e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CDKN1A—hepatitis B	6.12e-06	1.39e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PTEN—hepatitis B	6.11e-06	1.38e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NFKB1—hepatitis B	6.08e-06	1.38e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.01e-06	1.36e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—hepatitis B	5.98e-06	1.36e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—hepatitis B	5.97e-06	1.35e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—hepatitis B	5.95e-06	1.35e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—hepatitis B	5.9e-06	1.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—hepatitis B	5.89e-06	1.34e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—hepatitis B	5.82e-06	1.32e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—hepatitis B	5.73e-06	1.3e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—hepatitis B	5.69e-06	1.29e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—hepatitis B	5.61e-06	1.27e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—hepatitis B	5.53e-06	1.25e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—hepatitis B	5.5e-06	1.25e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	5.49e-06	1.24e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—hepatitis B	5.47e-06	1.24e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—hepatitis B	5.45e-06	1.24e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—hepatitis B	5.41e-06	1.23e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	5.36e-06	1.22e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PTEN—hepatitis B	5.35e-06	1.21e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—hepatitis B	5.33e-06	1.21e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—hepatitis B	5.33e-06	1.21e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NFKB1—hepatitis B	5.32e-06	1.21e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—hepatitis B	5.17e-06	1.17e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—hepatitis B	5.13e-06	1.16e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—hepatitis B	5.09e-06	1.15e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—hepatitis B	5.09e-06	1.15e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—hepatitis B	5.06e-06	1.15e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—hepatitis B	5.05e-06	1.15e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—hepatitis B	5.03e-06	1.14e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—hepatitis B	4.88e-06	1.11e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CTNNB1—hepatitis B	4.86e-06	1.1e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—hepatitis B	4.77e-06	1.08e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CDKN1A—hepatitis B	4.75e-06	1.08e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PTEN—hepatitis B	4.74e-06	1.07e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NFKB1—hepatitis B	4.71e-06	1.07e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—hepatitis B	4.62e-06	1.05e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—hepatitis B	4.58e-06	1.04e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—hepatitis B	4.55e-06	1.03e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—hepatitis B	4.45e-06	1.01e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTEN—hepatitis B	4.44e-06	1.01e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—hepatitis B	4.43e-06	1.01e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—hepatitis B	4.39e-06	9.96e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—hepatitis B	4.39e-06	9.94e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—hepatitis B	4.22e-06	9.58e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—hepatitis B	4.22e-06	9.57e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTEN—hepatitis B	4.2e-06	9.51e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—hepatitis B	4.17e-06	9.45e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—hepatitis B	4.16e-06	9.44e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—hepatitis B	4.08e-06	9.25e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—hepatitis B	4.01e-06	9.1e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—hepatitis B	3.93e-06	8.9e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—hepatitis B	3.86e-06	8.76e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—hepatitis B	3.82e-06	8.65e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—hepatitis B	3.65e-06	8.28e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—hepatitis B	3.51e-06	7.95e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTEN—hepatitis B	3.35e-06	7.6e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—hepatitis B	3.34e-06	7.58e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—hepatitis B	3.23e-06	7.33e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—hepatitis B	2.96e-06	6.71e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—hepatitis B	2.71e-06	6.14e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTEN—hepatitis B	2.67e-06	6.07e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTEN—hepatitis B	2.06e-06	4.68e-06	CbGpPWpGaD
